-
1
-
-
0026748207
-
Adenocarcinoma in Barrett's esophagus: A new epidemic?
-
Haggitt RC. Adenocarcinoma in Barrett's esophagus: a new epidemic? Hum Pathol. 1992;23:475-476.
-
(1992)
Hum Pathol
, vol.23
, pp. 475-476
-
-
Haggitt, R.C.1
-
2
-
-
28844461009
-
Prevalence of Barrett's esophagus in the general population: An endoscopic study
-
DOI 10.1053/j.gastro.2005.08.053, PII S0016508505017713
-
Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825-1831. (Pubitemid 41772961)
-
(2005)
Gastroenterology
, vol.129
, Issue.6
, pp. 1825-1831
-
-
Ronkainen, J.1
Aro, P.2
Storskrubb, T.3
Johansson, S.-E.4
Lind, T.5
Bolling-Sternevald, E.6
Vieth, M.7
Stolte, M.8
Talley, N.J.9
Agreus, L.10
-
3
-
-
0022253063
-
The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus
-
Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985;313: 857-859. (Pubitemid 15250200)
-
(1985)
New England Journal of Medicine
, vol.313
, Issue.14
, pp. 857-859
-
-
Cameron, A.J.1
Ott, B.J.2
Payne, W.S.3
-
4
-
-
0024505079
-
Barrett's esophagus: Development of dysplasia and adenocarcinoma
-
Hameeteman W, Tytgat GN, Houthoff HJ, et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989;96:1249-1256. (Pubitemid 19126659)
-
(1989)
Gastroenterology
, vol.96
, Issue.5
, pp. 1249-1256
-
-
Hameeteman, W.1
Tytgat, G.N.J.2
Houthoff, H.J.3
Van Den Tweel, J.G.4
-
5
-
-
0027301539
-
Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus
-
The Rotterdam Esophageal Tumor Study Group
-
Menke-Pluymers MB, Hop WC, Dees J, et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer. 1993;72:1155-1158.
-
(1993)
Cancer
, vol.72
, pp. 1155-1158
-
-
Menke-Pluymers, M.B.1
Hop, W.C.2
Dees, J.3
-
6
-
-
0030975048
-
Etiology of Barrett's metaplasia and esophageal adenocarcinoma
-
Kim R, Weissfeld JL, Reynolds JC, et al. Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 1997;6:369-377. (Pubitemid 27204029)
-
(1997)
Cancer Epidemiology Biomarkers and Prevention
, vol.6
, Issue.5
, pp. 369-377
-
-
Kim, R.1
Weissfeld, J.L.2
Reynolds, J.C.3
Kuller, L.H.4
-
7
-
-
0023840926
-
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions
-
Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology. 1988;94:81-90.
-
(1988)
Gastroenterology
, vol.94
, pp. 81-90
-
-
Reid, B.J.1
Weinstein, W.M.2
Lewin, K.J.3
-
8
-
-
0033869292
-
Long-term follow-up of Barrett's high-grade dysplasia
-
Weston AP, Sharma P, Topalovski M, et al. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol. 2000;95: 1888-1893.
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 1888-1893
-
-
Weston, A.P.1
Sharma, P.2
Topalovski, M.3
-
9
-
-
0027993158
-
Barrett's esophageus, dysplasia and adenocarcinoma
-
Haggitt RC. Barrett's esophageus, dysplasia and adenocarcinoma. Hum Pathol. 1994;25:982-993.
-
(1994)
Hum Pathol
, vol.25
, pp. 982-993
-
-
Haggitt, R.C.1
-
10
-
-
0034995578
-
Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia
-
Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2001;120:1607-1619. (Pubitemid 32523480)
-
(2001)
Gastroenterology
, vol.120
, Issue.7
, pp. 1607-1619
-
-
Schnell, T.G.1
Sontag, S.J.2
Chejfec, G.3
Aranha, G.4
Metz, A.5
O'Connell, S.6
Seidel, U.J.7
Sonnenberg, A.8
-
11
-
-
0023906902
-
Observer variation in the diagnosis of dysplasia in Barrett's esophagus
-
Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol. 1988;19: 166-178. (Pubitemid 18091022)
-
(1988)
Human Pathology
, vol.19
, Issue.2
, pp. 166-178
-
-
Reid, B.J.1
Haggitt, R.C.2
Rubin, C.E.3
Roth, G.4
Surawicz, C.M.5
Van Belle, G.6
Lewin, K.7
Weinstein, W.M.8
Antonioli, D.A.9
Goldman, H.10
MacDonald, W.11
Owen, D.12
-
12
-
-
0035028767
-
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation
-
DOI 10.1053/hupa.2001.23510
-
Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001;32:368-378. (Pubitemid 32378298)
-
(2001)
Human Pathology
, vol.32
, Issue.4
, pp. 368-378
-
-
Montgomery, E.1
Bronner, M.P.2
Goldblum, J.R.3
Greenson, J.K.4
Haber, M.M.5
Hart, J.6
Lamps, L.W.7
Lauwers, G.Y.8
Lazenby, A.J.9
Lewin, D.N.10
Robert, M.E.11
Toledano, A.Y.12
Shyr, Y.13
Washington, K.14
-
13
-
-
13444310790
-
Is There a way for pathologists to decrease interobserver variability in the diagnosis of dysplasia?
-
Montgomery E. Is There a way for pathologists to decrease interobserver variability in the diagnosis of dysplasia? Arch Pathol Lab Med. 2005;129:174-176.
-
(2005)
Arch Pathol Lab Med
, vol.129
, pp. 174-176
-
-
Montgomery, E.1
-
14
-
-
84966538496
-
Update on grading dysplasia in Barrett's esophagus
-
Montgomery E. Update on grading dysplasia in Barrett's esophagus. Pathol Case Rev. 2002;7:35-42.
-
(2002)
Pathol Case Rev
, vol.7
, pp. 35-42
-
-
Montgomery, E.1
-
15
-
-
0033859681
-
The diagnosis of dysplasia and malignancy in Barrett's oesophagus
-
DOI 10.1046/j.1365-2559.2000.00960.x
-
Geboes K, van Eyken P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology. 2000;37:99-107. (Pubitemid 30608506)
-
(2000)
Histopathology
, vol.37
, Issue.2
, pp. 99-107
-
-
Geboes, K.1
Van Eyken, P.2
-
17
-
-
27244449307
-
Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: Evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications
-
DOI 10.1097/01.pas.0000170349.47680.e8
-
Powell EL, Leoni LM, Canto MI, et al. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications. Am J Surg Pathol. 2005;29:1497-1504. (Pubitemid 41513300)
-
(2005)
American Journal of Surgical Pathology
, vol.29
, Issue.11
, pp. 1497-1504
-
-
Powell, E.L.1
Leoni, L.M.2
Canto, M.I.3
Forastiere, A.A.4
Iocobuzio-Donahue, C.A.5
Wang, J.S.6
Maitra, A.7
Montgomery, E.8
-
18
-
-
11144282431
-
p16 expression in Barrett's esophagus and esophageal adenocarcinoma: Association with genetic and epigenetic alterations
-
Hardie LJ, Darnton SJ, Wallis YL, et al. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations. Cancer Lett. 2005;217:221-230.
-
(2005)
Cancer Lett
, vol.217
, pp. 221-230
-
-
Hardie, L.J.1
Darnton, S.J.2
Wallis, Y.L.3
-
19
-
-
4544301235
-
INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma
-
DOI 10.1007/s00428-004-1042-0
-
Vieth M, Schneider-Stock R, Rohrich K, et al. INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma. Virch Archiv. 2004;445:135-141. (Pubitemid 39215544)
-
(2004)
Virchows Archiv
, vol.445
, Issue.2
, pp. 135-141
-
-
Vieth, M.1
Schneider-Stock, R.2
Rohrich, K.3
May, A.4
Ell, C.5
Markwarth, A.6
Roessner, A.7
Stolte, M.8
Tannapfel, A.9
-
20
-
-
0037352816
-
3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia
-
Sanz-Ortega J, Hernandez S, Saez MC, et al. 3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia. Hepato-Gastroenterology. 2003;50: 404-407. (Pubitemid 36390530)
-
(2003)
Hepato-Gastroenterology
, vol.50
, Issue.50
, pp. 404-407
-
-
Sanz-Ortega, J.1
Hernandez, S.2
Saez, M.C.3
Sierra, E.4
Sanz-Ortega, G.5
Torres, A.6
Balibrea, J.L.7
Sanz-Esponera, J.8
Merino, M.J.9
-
21
-
-
33645682837
-
Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus
-
Merola E, Mattioli E, Minimo C, et al. Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus. J Cell Physiol. 2006;207: 512-519.
-
(2006)
J Cell Physiol
, vol.207
, pp. 512-519
-
-
Merola, E.1
Mattioli, E.2
Minimo, C.3
-
22
-
-
31844446633
-
Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16 in Rb-functional and Rb-inactivated tumor cells
-
DOI 10.1002/ijc.21466
-
Nilsson K, Landberg G. Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16 in Rb-functional and Rb-inactivated tumor cells. Int J Cancer. 2006;118:1120-1125. (Pubitemid 43185597)
-
(2006)
International Journal of Cancer
, vol.118
, Issue.5
, pp. 1120-1125
-
-
Nilsson, K.1
Landberg, G.2
-
23
-
-
33947670366
-
Up-regulation of expression and lack of 50 CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas
-
Ivanova TA, Golovina DA, Zavalishina LE, et al. Up-regulation of expression and lack of 50 CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas. BMC Cancer. 2007;7:47.
-
(2007)
BMC Cancer
, vol.7
, pp. 47
-
-
Ivanova, T.A.1
Golovina, D.A.2
Zavalishina, L.E.3
-
24
-
-
20044394366
-
INK4a promoter methylation and protein expression in breast fibroadenoma and carcinoma
-
DOI 10.1002/ijc.20771
-
Di Vinci A, Perdelli L, Banelli B, et al. P16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma. Int J Cancer. 2005;114:414-421. (Pubitemid 40279962)
-
(2005)
International Journal of Cancer
, vol.114
, Issue.3
, pp. 414-421
-
-
Di Vinci, A.1
Perdelli, L.2
Banelli, B.3
Salvi, S.4
Casciano, I.5
Gelvi, I.6
Allemanni, G.7
Margallo, E.8
Gatteschi, B.9
Romani, M.10
-
25
-
-
33750817623
-
Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence
-
Zhao P, Mao X, Talbot IC. Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence. World J Gastroenterol. 2006;12:6391-6396. (Pubitemid 44712426)
-
(2006)
World Journal of Gastroenterology
, vol.12
, Issue.39
, pp. 6391-6396
-
-
Zhao, P.1
Mao, X.2
Talbot, I.C.3
-
26
-
-
0032770368
-
P53, p21 (Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer
-
Kuwahara M, Hirai T, Yoshida K, et al. p53, p21 (Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer. Dis Esophagus. 1999;12:116-119.
-
(1999)
Dis Esophagus
, vol.12
, pp. 116-119
-
-
Kuwahara, M.1
Hirai, T.2
Yoshida, K.3
-
27
-
-
0034674912
-
Prospective study of cyclin D1 overexpression in Barrett's esophagus: Association with increased risk of adenocarcinoma
-
Bani-Hani K, Martin IG, Hardie LJ, et al. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst. 2000;92: 1316-1321. (Pubitemid 30660591)
-
(2000)
Journal of the National Cancer Institute
, vol.92
, Issue.16
, pp. 1316-1321
-
-
Bani-Hani, K.1
Martin, I.G.2
Hardie, L.J.3
Mapstone, N.4
Briggs, J.A.5
Forman, D.6
Wild, C.P.7
-
28
-
-
19144370749
-
Increased expression of the cyclin D1 gene in Barrett's esophagus
-
Arber N, Gammon MD, Hibshoosh H, et al. Increased expression of the cyclin D1 gene in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 1996;5:457-459. (Pubitemid 26182660)
-
(1996)
Cancer Epidemiology Biomarkers and Prevention
, vol.5
, Issue.6
, pp. 457-459
-
-
Arber, N.1
Lightdale, C.2
Rotterdam, H.3
Han, E.K.-H.4
Sgambato, A.5
Yap, E.6
Ahsan, H.7
Finegold, J.8
Stevens, P.D.9
Green, P.H.R.10
Hibshoosh, H.11
Neugut, A.I.12
Holt, P.R.13
Weinstein, I.B.14
-
29
-
-
11144330624
-
Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis
-
DOI 10.1593/neo.04280
-
Lao-Sirieix P, Brais R, Lovat L, et al. Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis. Neoplasia. 2004;6:751-760. (Pubitemid 40041493)
-
(2004)
Neoplasia
, vol.6
, Issue.6
, pp. 751-760
-
-
Lao-Sirieix, P.1
Brais, R.2
Lovat, L.3
Coleman, N.4
Fitzgerald, R.C.5
-
30
-
-
2542477282
-
Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody
-
DOI 10.1097/01.pas.0000126054.95798.94
-
Cheuk W, Wong KO, Wong CS, Chan JK. Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody. Am J Surg Pathol. 2004;28:801-807. (Pubitemid 38685895)
-
(2004)
American Journal of Surgical Pathology
, vol.28
, Issue.6
, pp. 801-807
-
-
Cheuk, W.1
Wong, K.O.Y.2
Wong, C.S.C.3
Chan, J.K.C.4
-
31
-
-
34247634690
-
Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia- Dysplasia-adenocarcinoma sequence
-
Griffiths EA, Pritchard SA, McGrath SM, et al. Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia- dysplasia-adenocarcinoma sequence. Br J Cancer. 2007;96: 1377-1383.
-
(2007)
Br J Cancer
, vol.96
, pp. 1377-1383
-
-
Griffiths, E.A.1
Pritchard, S.A.2
McGrath, S.M.3
-
32
-
-
0033807824
-
Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma- sequence of Barrett's esophagus
-
Halm U, Tannapfel A, Breitung B, et al. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus. Hepatogastroenterology. 2000;47:962-966. (Pubitemid 30746235)
-
(2000)
Hepato-Gastroenterology
, vol.47
, Issue.34
, pp. 962-966
-
-
Halm, U.1
Tannapfel, A.2
Breitung, B.3
Breidert, M.4
Wittekind, C.W.5
Mossner, J.6
-
33
-
-
0029119205
-
The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence
-
Polkowski W, van Lanschot JJ, Ten Kate FJ, et al. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol. 1995;4:163-171.
-
(1995)
Surg Oncol
, vol.4
, pp. 163-171
-
-
Polkowski, W.1
Van Lanschot, J.J.2
Ten Kate, F.J.3
-
34
-
-
0028888513
-
Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus
-
Hong MK, Laskin WB, Herman BE, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer. 1995;75:423-429.
-
(1995)
Cancer
, vol.75
, pp. 423-429
-
-
Hong, M.K.1
Laskin, W.B.2
Herman, B.E.3
-
35
-
-
0033747547
-
Subcellular localization and physiological role of α-methylacyl-CoA racemase
-
Ferdinandusse S, Denis S, IJlst L, et al. Subcellular localization and physiological role of a α-methylacyl-CoA racemase. J Lipid Res. 2000;41:1890-1896. (Pubitemid 30839731)
-
(2000)
Journal of Lipid Research
, vol.41
, Issue.11
, pp. 1890-1896
-
-
Ferdinandusse, S.1
Denis, S.2
Ijlst, L.3
Dacremont, G.4
Waterham, H.R.5
Wanders, R.J.A.6
-
36
-
-
0034765524
-
P504S: A new molecular marker for the detection of prostate carcinoma
-
DOI 10.1097/00000478-200111000-00007
-
Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25: 1397-1404. (Pubitemid 33022055)
-
(2001)
American Journal of Surgical Pathology
, vol.25
, Issue.11
, pp. 1397-1404
-
-
Jiang, Z.1
Woda, B.A.2
Rock, K.L.3
Xu, Y.4
Savas, L.5
Khan, A.6
Pihan, G.7
Cai, F.8
Babcook, J.S.9
Rathanaswami, P.10
Reed, S.G.11
Xu, J.12
Fanger, G.R.13
-
37
-
-
0037012476
-
α-methylacyl coenzyme a racemase as a tissue biomarker for prostate cancer
-
Rubin MA, Zhou M, Dhanasekaran SM, et al. a-Methylacyl coenzyme a racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287:1662-1670. (Pubitemid 34289218)
-
(2002)
Journal of the American Medical Association
, vol.287
, Issue.13
, pp. 1662-1670
-
-
Rubin, M.A.1
Zhou, M.2
Dhanasekaran, S.M.3
Varambally, S.4
Barrette, T.R.5
Sanda, M.G.6
Pienta, K.J.7
Ghosh, D.8
Chinnaiyan, A.M.9
-
38
-
-
10744220888
-
A dietary enzyme: α-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma
-
DOI 10.1016/j.cdp.2003.07.003
-
Jiang Z, Fanger GR, Banner BF, et al. A dietary enzyme: a-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect Prev. 2003;27:422-426. (Pubitemid 37506955)
-
(2003)
Cancer Detection and Prevention
, vol.27
, Issue.6
, pp. 422-426
-
-
Jiang, Z.1
Fanger, G.R.2
Banner, B.F.3
Woda, B.A.4
Algate, P.5
Dresser, K.6
Xu, J.7
Reed, S.G.8
Rock, K.L.9
Chu, P.G.10
-
39
-
-
34249741574
-
Alpha-methylacyl-CoA Racemase/P504S overexpression in colorectal carcinoma is correlated with tumor differentiation
-
Shi X, Gong E, Wu X. Alpha-methylacyl-CoA Racemase/P504S overexpression in colorectal carcinoma is correlated with tumor differentiation. Appl Immunohistochem Mol Morphol. 2007;15: 175-180.
-
(2007)
Appl Immunohistochem Mol Morphol
, vol.15
, pp. 175-180
-
-
Shi, X.1
Gong, E.2
Wu, X.3
-
40
-
-
20444406074
-
α-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis
-
DOI 10.1158/1055-9965.EPI-04-0607
-
Witkiewicz AK, Varambally S, Shen R, et al. Alpha-methylacyl- CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. Cancer Epidemiol Biomarkers Prev. 2005;14:1418-1423. (Pubitemid 40807340)
-
(2005)
Cancer Epidemiology Biomarkers and Prevention
, vol.14
, Issue.6
, pp. 1418-1423
-
-
Witkiewicz, A.K.1
Varambally, S.2
Shen, R.3
Mehra, R.4
Sabel, M.S.5
Ghosh, D.6
Chinnaiyan, A.M.7
Rubin, M.A.8
Kleer, C.G.9
-
41
-
-
33746930644
-
AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease
-
DOI 10.1097/01.pas.0000213268.30468.b4, PII 0000047820060700000012
-
Dorer R, Odze RD. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease. Am J Surg Pathol. 2006;30:871-877. (Pubitemid 44264978)
-
(2006)
American Journal of Surgical Pathology
, vol.30
, Issue.7
, pp. 871-877
-
-
Dorer, R.1
Odze, R.D.2
-
42
-
-
33751208046
-
Expression of α-methylacyl-coenzyme a racemase in dysplastic Barrett's epithelium
-
DOI 10.1016/j.humpath.2006.06.009, PII S0046817706003789
-
Lisovsky M, Falkowski O, Bhuiya T. Expression of alphamethylacyl- coenzyme A racemase in dysplastic Barrett's epithelium. Hum Pathol. 2006;37:1601-1606. (Pubitemid 44792228)
-
(2006)
Human Pathology
, vol.37
, Issue.12
, pp. 1601-1606
-
-
Lisovsky, M.1
Falkowski, O.2
Bhuiya, T.3
|